Cargando…

Regulatory T Cells as Immunotherapy

Regulatory T cells (Tregs) suppress exuberant immune system activation and promote immunologic tolerance. Because Tregs modulate both innate and adaptive immunity, the biomedical community has developed an intense interest in using Tregs for immunotherapy. Conditions that require clinical tolerance...

Descripción completa

Detalles Bibliográficos
Autores principales:	Singer, Benjamin D., King, Landon S., D’Alessio, Franco R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2014
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3920065/ https://www.ncbi.nlm.nih.gov/pubmed/24575095 http://dx.doi.org/10.3389/fimmu.2014.00046

Ejemplares similares

Foxp3(+) Regulatory T Cells Promote Lung Epithelial Proliferation
por: Mock, Jason R., et al.
Publicado: (2014)

Regulatory Dendritic Cells for Immunotherapy in Immunologic Diseases
por: Gordon, John R., et al.
Publicado: (2014)

Epigenetic Control of Regulatory T Cell Stability and Function: Implications for Translation
por: Joudi, Anthony M., et al.
Publicado: (2022)

Functional Diversities of Regulatory T Cells in the Context of Cancer Immunotherapy
por: Gao, Ran, et al.
Publicado: (2022)

The Role of Regulatory T Cells in Epicutaneous Immunotherapy for Food Allergy
por: Liu, Guirong, et al.
Publicado: (2021)

Application of Regulatory Cell Death in Cancer: Based on Targeted Therapy and Immunotherapy
por: Qi, Xiaochen, et al.
Publicado: (2022)

Pancreatic cancer: Emerging field of regulatory B-cell-targeted immunotherapies
por: Senturk, Zeynep Nur, et al.
Publicado: (2023)

The Next Frontier of Regulatory T Cells: Promising Immunotherapy for Autoimmune Diseases and Organ Transplantations
por: Terry, Lauren V., et al.
Publicado: (2020)

Non-coding RNA in tumor-infiltrating regulatory T cells formation and associated immunotherapy
por: Ma, Yue, et al.
Publicado: (2023)

Partial CD25 Antagonism Enables Dominance of Antigen-Inducible CD25(high) FOXP3(+) Regulatory T Cells As a Basis for a Regulatory T Cell-Based Adoptive Immunotherapy
por: Wilkinson, Daniel S., et al.
Publicado: (2017)

The Potential Regulatory Roles of Circular RNAs in Tumor Immunology and Immunotherapy
por: Fang, Zhixiao, et al.
Publicado: (2021)

Actors and Factors in the Resolution of Intestinal Inflammation: Lipid Mediators As a New Approach to Therapy in Inflammatory Bowel Diseases
por: Ungaro, Federica, et al.
Publicado: (2017)

Gamma Delta T-Cell Based Cancer Immunotherapy: Past-Present-Future
por: Saura-Esteller, José, et al.
Publicado: (2022)

Regulatory T cells are associated with the tumor immune microenvironment and immunotherapy response in triple-negative breast cancer
por: Huang, Pengfei, et al.
Publicado: (2023)

The Role of Membrane Bound Complement Regulatory Proteins in Tumor Development and Cancer Immunotherapy
por: Geller, Anne, et al.
Publicado: (2019)

Cytolytic CD4(+) and CD8(+) Regulatory T-Cells and Implications for Developing Immunotherapies to Combat Graft-Versus-Host Disease
por: Bolivar-Wagers, Sara, et al.
Publicado: (2022)

Immunotherapy With Recombinant Alt a 1 Suppresses Allergic Asthma and Influences T Follicular Cells and Regulatory B Cells in Mice
por: Liu, Juan, et al.
Publicado: (2021)

Estradiol resolves pneumonia via ERβ in regulatory T cells
por: Xiong, Ye, et al.
Publicado: (2021)

Antigen Uptake by Langerhans Cells Is Required for the Induction of Regulatory T Cells and the Acquisition of Tolerance During Epicutaneous Immunotherapy in OVA-Sensitized Mice
por: Dioszeghy, Vincent, et al.
Publicado: (2018)

Computational Recognition of a Regulatory T-cell-specific Signature With Potential Implications in Prognosis, Immunotherapy, and Therapeutic Resistance of Prostate Cancer
por: Ju, Mingyi, et al.
Publicado: (2022)

Editorial: The immunosuppressive tumor microenvironment and strategies to revert its immune regulatory milieu for cancer immunotherapy
por: Ganjalikhani Hakemi, Mazdak, et al.
Publicado: (2023)

CD1d-Invariant Natural Killer T Cell-Based Cancer Immunotherapy: α-Galactosylceramide and Beyond
por: King, Lisa A., et al.
Publicado: (2018)

Stromal Cell Induction of Regulatory Dendritic Cells
por: Owens, Benjamin M. J., et al.
Publicado: (2012)

T Cell Recognition of Tumor Neoantigens and Insights Into T Cell Immunotherapy
por: Sim, Malcolm J. W., et al.
Publicado: (2022)

Harnessing Unconventional T Cells for Immunotherapy of Tuberculosis
por: La Manna, Marco P., et al.
Publicado: (2020)

Successful expansion of functional and stable regulatory T cells for immunotherapy in liver transplantation
por: Safinia, Niloufar, et al.
Publicado: (2016)

Corrigendum: CD1d-Invariant Natural Killer T Cell-Based Cancer Immunotherapy: α-Galactosylceramide and Beyond
por: King, Lisa A., et al.
Publicado: (2018)

The application of autologous cancer immunotherapies in the age of memory-NK cells
por: Lizana-Vasquez, Gaby D., et al.
Publicado: (2023)

Dexamethasone-Induced FKBP51 Expression in CD4(+) T-Lymphocytes Is Uniquely Associated With Worse Asthma Control in Obese Children With Asthma
por: Tejwani, Vickram, et al.
Publicado: (2021)

Successful Milk Oral Immunotherapy Promotes Generation of Casein-Specific CD137(+) FOXP3(+) Regulatory T Cells Detectable in Peripheral Blood
por: Zhang, Yi, et al.
Publicado: (2021)

Novel Approaches to Exploiting Invariant NKT Cells in Cancer Immunotherapy
por: Wolf, Benjamin J., et al.
Publicado: (2018)

Do Natural T Regulatory Cells become Activated to Antigen Specific T Regulatory Cells in Transplantation and in Autoimmunity?
por: Hall, Bruce M., et al.
Publicado: (2013)

Regulatory T Cells Suppress Effector T Cell Proliferation by Limiting Division Destiny
por: Dowling, Mark R., et al.
Publicado: (2018)

Dendritic Cells and Their Role in Immunotherapy
por: Gardner, Alycia, et al.
Publicado: (2020)

Thymic Function and T-Cell Receptor Repertoire Diversity: Implications for Patient Response to Checkpoint Blockade Immunotherapy
por: Cardinale, Antonella, et al.
Publicado: (2021)

Tregalizumab – A Monoclonal Antibody to Target Regulatory T Cells
por: König, Martin, et al.
Publicado: (2016)

Oral Immunotherapy and Basophil and Mast Cell Reactivity in Food Allergy
por: Paranjape, Anuya, et al.
Publicado: (2020)

Lineage Reprogramming of Effector Regulatory T Cells in Cancer
por: Dixon, Michael L., et al.
Publicado: (2021)

Enhancing Neuroblastoma Immunotherapies by Engaging iNKT and NK Cells
por: McNerney, Kevin O., et al.
Publicado: (2020)

Invariant Natural Killer T Cells in Immune Regulation of Blood Cancers: Harnessing Their Potential in Immunotherapies
por: Lam, Pui Yeng, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_bkgdobknvsa79fj825gatogoo1